C12Q 2334/22
4-methylumbelliferyl, i.e. beta-methylumbelliferone, 4mu
Official title: 4-Methylumbelliferyl, i.e. beta-methylumbelliferone, 4MU
C12Q2334/22 (4-methylumbelliferyl, i.e. beta-methylumbelliferone, 4mu) appears on 43 US grants and 13 published applications in this corpus.
Search patents in C12Q- Granted patents
- 43
- Published applications
- 13
- Assignees
- 34
- Inventors
- 85
- Latest grant
- 14 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 1 |
| 2003 | 4 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 2 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Saposin C pharmaceutical compositions and methods of treating cancer14 Jan 2025US 12,194,099 B2Bexion Pharmaceuticals Inc.
- Fluorescence based extracellular enzyme activity assay for early detection of biofouling in seawater desalination systems15 Aug 2023US 11,726,026 B2King Abdullah University of Science and Technology
- Saposin C pharmaceutical compositions and methods of treating cancer28 Feb 2023US 11,590,227 B2Bexion Pharmaceuticals Inc.
- Culture medium for detection of bacterium belonging to genus Listeria29 Nov 2022US 11,512,338 B2Nissui Pharmaceutical Co., Ltd.
- Method and kit for detecting pathogenic microorganism18 May 2021US 11,008,603 B2Japan Science and Technology Agency
- High throughput, fluorescence-based esterase activity assay for assessing polysorbate degradation risk during biopharmaceutical development2 Nov 2023US 2023/0348953 A1Genentech, Inc.
- Saposin c pharmaceutical compositions and methods of treating cancer20 Jul 2023US 2023/0226188 A1Bexion Pharmaceuticals Inc.
- Culture medium for detection of bacterium belonging to genus listeria18 Mar 2021US 2021/0079439 A1Nissui Pharmaceutical Co., Ltd.
- Saposin c pharmaceutical compositions and methods of treating cancer10 Dec 2020US 2020/0384112 A1Bexion Pharmaceuticals Inc.
- Fluorescence based extracellular enzyme activity assay for early detection of biofouling in seawater desalination systems20 Feb 2020US 2020/0056982 A1King Abdullah University of Science and Technology
Most cited
By later US patents
- Rapid method for detecting microorganisms71US 4,591,554 AAjinomoto Co., Inc. · 1986
- Rapid process for detection coliform bacteria42US 5,292,644 A1994
- Microorganism testing with a hydrolyzable fluorogenic substrate38US 5,079,144 ARadiometer Corporate Development Ltd. · 1992
- Rapid readout sterilization indicator for liquid peracetic acid sterilization procedures34US 6,352,837 B13M Innovative Properties Company · 2002
- Microbial susceptibility assay using 7-N-(aminoacyl)-7-amido-4-methylcoumarins29US 5,064,756 A1991